后大脑动脉闭塞卒中的血管内治疗与药物治疗比较:PLATO研究
这项多国病例对照研究纳入2015年1月至2022年8月间欧洲和北美27个中心连续就诊的孤立性后大脑动脉闭塞患者,比较血管内治疗与药物治疗的临床结局。结果显示两组90天改良Rankin量表序贯移位无差异,但血管内治疗组NIHSS评分改善≥2分的比值更高,且症状性颅内出血和死亡率也更高。
要点
- 血管内治疗与药物治疗的90天改良Rankin量表序贯移位无显著差异(aOR 1.13,95%CI 0.85-1.50,P=0.41)。
- 血管内治疗组NIHSS评分改善≥2分的比值更高(aOR 1.84,95%CI 1.35-2.52,P=0.0001)。
- 血管内治疗组症状性颅内出血(6.2% vs 1.7%)和死亡率(10.1% vs 5.0%)均更高。
核心结论
- 在孤立性后大脑动脉闭塞患者中,血管内治疗与药物治疗相比,90天改良Rankin量表序贯移位所反映的残疾比值相似,但早期NIHSS评分改善和完全视力恢复的比值更高。
- 血管内治疗组获得极佳结局的可能性更高,但症状性颅内出血和死亡率也更高。
- 作者认为需要继续入组正在进行的远端血管闭塞随机试验。
研究设计与样本
- 多国病例对照研究,在欧洲和北美27个中心开展,纳入2015年1月至2022年8月间最后已知良好时间24小时内就诊的连续孤立性后大脑动脉闭塞患者。
- 共纳入1023例患者,其中男性589例(57.6%),中位年龄74岁(四分位距64-82岁)。
- 采用多变量逻辑回归和逆概率治疗加权比较血管内治疗组与药物治疗组。
- 共同主要结局为90天改良Rankin量表序贯移位和NIHSS评分下降≥2分。
主要发现
- 中位NIHSS评分为6分(四分位距3-10分),闭塞段位于P1段41.2%、P2段49.2%、P3段7.1%。
- 总体静脉溶栓率为43%,血管内治疗率为37%。
- 血管内治疗组与药物治疗组90天改良Rankin量表序贯移位无差异(aOR 1.13,95%CI 0.85-1.50,P=0.41)。
- 血管内治疗组NIHSS评分下降≥2分的比值更高(aOR 1.84,95%CI 1.35-2.52,P=0.0001)。
- 与药物治疗相比,血管内治疗与极佳结局可能性更高相关(aOR 1.50,95%CI 1.07-2.09,P=0.018),并与完全视力恢复相关,功能独立(改良Rankin量表评分0-2分)率相似,但症状性颅内出血率更高(6.2% vs 1.7%,P=0.0001),死亡率更高(10.1% vs 5.0%,P=0.002)。
关键数值与推荐
- 90天改良Rankin量表序贯移位:血管内治疗组 vs 药物治疗组 aOR 1.13(95%CI 0.85-1.50),P=0.41,无显著差异。
- NIHSS评分下降≥2分:血管内治疗组 vs 药物治疗组 aOR 1.84(95%CI 1.35-2.52),P=0.0001。
- 极佳结局:血管内治疗组 vs 药物治疗组 aOR 1.50(95%CI 1.07-2.09),P=0.018。
- 症状性颅内出血:血管内治疗组6.2% vs 药物治疗组1.7%,P=0.0001。
- 死亡率:血管内治疗组10.1% vs 药物治疗组5.0%,P=0.002。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal management of patients with isolated posterior cerebral artery occlusion is uncertain. We compared clinical outcomes for endovascular therapy (EVT) versus medical management (MM) in patients with isolated posterior cerebral artery occlusion. METHODS: This multinational case-control study conducted at 27 sites in Europe and North America included consecutive patients with isolated posterior cerebral artery occlusion presenting within 24 hours of time last well from January 2015 to August 2022. Patients treated with EVT or MM were compared with multivariable logistic regression and inverse probability of treatment weighting. The coprimary outcomes were the 90-day modified Rankin Scale ordinal shift and ≥2-point decrease in the National Institutes of Health Stroke Scale. RESULTS: Of 1023 patients, 589 (57.6%) were male with median (interquartile range) age of 74 (64-82) years. The median (interquartile range) National Institutes of Health Stroke Scale was 6 (3-10). The occlusion segments were P1 (41.2%), P2 (49.2%), and P3 (7.1%). Overall, intravenous thrombolysis was administered in 43% and EVT in 37%. There was no difference between the EVT and MM groups in the 90-day modified Rankin Scale shift (aOR, 1.13 [95% CI, 0.85-1.50]; P=0.41). There were higher odds of a decrease in the National Institutes of Health Stroke Scale by ≥2 points with EVT (aOR, 1.84 [95% CI, 1.35-2.52]; P=0.0001). Compared with MM, EVT was associated with a higher likelihood of excellent outcome (aOR, 1.50 [95% CI, 1.07-2.09]; P=0.018), complete vision recovery, and similar rates of functional independence (modified Rankin Scale score, 0-2), despite a higher rate of SICH and mortality (symptomatic intracranial hemorrhage, 6.2% versus 1.7%; P=0.0001; mortality, 10.1% versus 5.0%; P=0.002). CONCLUSIONS: In patients with isolated posterior cerebral artery occlusion, EVT was associated with similar odds of disability by ordinal modified Rankin Scale, higher odds of early National Institutes of Health stroke scale improvement, and complete vision recovery compared with MM. There was a higher likelihood of excellent outcome in the EVT group despite a higher rate of symptomatic intracranial hemorrhage and mortality. Continued enrollment into ongoing distal vessel occlusion randomized trials is warranted.
引用
- Nguyen TN, Qureshi MM, Strambo D, et al. Endovascular Versus Medical Management of Posterior Cerebral Artery Occlusion Stroke: The PLATO Study. Stroke. 2023. PMID: 37222709. doi:10.1161/STROKEAHA.123.042674
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。